DePuy Synthes reports 1.9% drop in sales for 2018: 5 things to know

Written by Laura Dyrda | January 23, 2019 | Print  |

Johnson & Johnson reported fourth quarter and full-year results for DePuy Synthes, its orthopedics division.

Five things to know:

1. In the fourth quarter, DePuy Synthes reported a 1 percent decrease in sales to $2.2 billion.

2. Fourth quarter hip sales reached $365 million, flat from the same period last year. Knee sales dropped 1.3 percent to $392 million, while trauma remained flat at $674 million. Spine and other sales dropped 2.9 percent to $831 million.

3. For the full year, DePuy Synthes sales dropped 1.9 percent to $8.8 billion.

4. 2018 full-year breakdown of orthopedic sales includes:

• Hips: $1.4 billion (1.7 percent increase)
• Knees: $1.5 billion (1.4 percent decrease)
• Trauma: $2.7 billion (3.2 percent increase)
• Spine and other: $3.2 billion (7.3 percent decrease)

5. In 2018, the company reported strong market demand for the ACTIS stem.

More articles on orthopedics:
How an orthopedic practice grew revenue 75%, physicians 40% in 5 years
California hospital receives $1M donation for orthopedic robotics center
Moody's Robotics to expand rapidly in orthopedics

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months